Literature DB >> 31337872

LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases.

Taiki Abe1, Ikumi Umeki2, Shin-Ichiro Kanno3, Shin-Ichi Inoue2, Tetsuya Niihori2, Yoko Aoki4.   

Abstract

Leucine zipper-like transcriptional regulator 1 (LZTR1) encodes a member of the BTB-Kelch superfamily, which interacts with the Cullin3 (CUL3)-based E3 ubiquitin ligase complex. Mutations in LZTR1 have been identified in glioblastoma, schwannomatosis, and Noonan syndrome. However, the functional role of LZTR1 in carcinogenesis or human development is not fully understood. Here, we demonstrate that LZTR1 facilitates the polyubiquitination and degradation of RAS via the ubiquitin-proteasome pathway, leading to the inhibition of the RAS/MAPK signaling. The polyubiquitination and degradation of RAS was also observed in cells expressing MRAS, HRAS, NRAS, and KRAS as well as oncogenic RAS mutants and inhibited the activation of ERK1/2 and cell growth. In vivo ubiquitination assays showed that MRAS-K127 and HRAS-K170 were ubiquitinated by LZTR1 and that the polyubiquitinated-chains contained mainly Ub-K48, K63, and K33-linked chains, suggesting its possible involvement in autophagy. Immunoprecipitation analyses showed the interaction of LZTR1 and RAS-GTPases with autophagy-related proteins, including LC3B and SQSTM1/p62. Co-expression of LZTR1 and RAS increased the expression of lipidated form of LC3B. However, long-term treatment with chloroquine had little effect on RAS protein levels, suggesting that the contribution of autophagy to LZTR1-mediated RAS degradation is minimal. Taken together, these results show that LZTR1 functions as a "RAS killer protein" mainly via the ubiquitin-proteasome pathway regardless of the type of RAS GTPase, controlling downstream signal transduction. Our results also suggest a possible association of LZTR1 and RAS-GTPases with the autophagy. These findings provide clues for the elucidation of the mechanisms of RAS degradation and regulation of the RAS/MAPK signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31337872      PMCID: PMC7206011          DOI: 10.1038/s41418-019-0395-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  36 in total

Review 1.  The BACK domain in BTB-kelch proteins.

Authors:  Peter J Stogios; Gilbert G Privé
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

2.  Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing.

Authors:  Sara Franceschi; Francesca Lessi; Paolo Aretini; Chiara M Mazzanti; Michele Menicagli; Marco La Ferla; Veronica De Gregorio; Davide Caramella; Antonio G Naccarato; Generoso Bevilacqua; Angelo G Bonadio; Francesco Pasqualetti
Journal:  Neuro Oncol       Date:  2016-02       Impact factor: 12.300

3.  The BTB-kelch protein LZTR-1 is a novel Golgi protein that is degraded upon induction of apoptosis.

Authors:  Tanju G Nacak; Kerstin Leptien; Doris Fellner; Hellmut G Augustin; Jens Kroll
Journal:  J Biol Chem       Date:  2005-12-15       Impact factor: 5.157

4.  Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.

Authors:  Guilherme Lopes Yamamoto; Meire Aguena; Monika Gos; Christina Hung; Jacek Pilch; Somayyeh Fahiminiya; Anna Abramowicz; Ingrid Cristian; Michelle Buscarilli; Michel Satya Naslavsky; Alexsandra C Malaquias; Mayana Zatz; Olaf Bodamer; Jacek Majewski; Alexander A L Jorge; Alexandre C Pereira; Chong Ae Kim; Maria Rita Passos-Bueno; Débora Romeo Bertola
Journal:  J Med Genet       Date:  2015-03-20       Impact factor: 6.318

Review 5.  A CULLINary ride across the secretory pathway: more than just secretion.

Authors:  Albert Lu; Suzanne R Pfeffer
Journal:  Trends Cell Biol       Date:  2014-03-11       Impact factor: 20.808

6.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Authors:  Arkadiusz Piotrowski; Jing Xie; Ying F Liu; Andrzej B Poplawski; Alicia R Gomes; Piotr Madanecki; Chuanhua Fu; Michael R Crowley; David K Crossman; Linlea Armstrong; Dusica Babovic-Vuksanovic; Amanda Bergner; Jaishri O Blakeley; Andrea L Blumenthal; Molly S Daniels; Howard Feit; Kathy Gardner; Stephanie Hurst; Christine Kobelka; Chung Lee; Rebecca Nagy; Katherine A Rauen; John M Slopis; Pim Suwannarat; Judith A Westman; Andrea Zanko; Bruce R Korf; Ludwine M Messiaen
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

7.  BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases.

Authors:  Rory Geyer; Susan Wee; Scott Anderson; John Yates; Dieter A Wolf
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

8.  Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.

Authors:  Manabu Furukawa; Yizhou Joseph He; Christoph Borchers; Yue Xiong
Journal:  Nat Cell Biol       Date:  2003-10-05       Impact factor: 28.824

9.  Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants.

Authors:  Jennifer J Johnston; Jasper J van der Smagt; Jill A Rosenfeld; Alistair T Pagnamenta; Abdulrahman Alswaid; Eva H Baker; Edward Blair; Guntram Borck; Julia Brinkmann; William Craigen; Vu Chi Dung; Lisa Emrick; David B Everman; Koen L van Gassen; Suleyman Gulsuner; Margaret H Harr; Mahim Jain; Alma Kuechler; Kathleen A Leppig; Donna M McDonald-McGinn; Ngoc Thi Bich Can; Amir Peleg; Elizabeth R Roeder; R Curtis Rogers; Lena Sagi-Dain; Julie C Sapp; Alejandro A Schäffer; Denny Schanze; Helen Stewart; Jenny C Taylor; Nienke E Verbeek; Magdalena A Walkiewicz; Elaine H Zackai; Christiane Zweier; Martin Zenker; Brendan Lee; Leslie G Biesecker
Journal:  Genet Med       Date:  2018-02-22       Impact factor: 8.822

10.  The integrated landscape of driver genomic alterations in glioblastoma.

Authors:  Veronique Frattini; Vladimir Trifonov; Joseph Minhow Chan; Angelica Castano; Marie Lia; Francesco Abate; Stephen T Keir; Alan X Ji; Pietro Zoppoli; Francesco Niola; Carla Danussi; Igor Dolgalev; Paola Porrati; Serena Pellegatta; Adriana Heguy; Gaurav Gupta; David J Pisapia; Peter Canoll; Jeffrey N Bruce; Roger E McLendon; Hai Yan; Ken Aldape; Gaetano Finocchiaro; Tom Mikkelsen; Gilbert G Privé; Darell D Bigner; Anna Lasorella; Raul Rabadan; Antonio Iavarone
Journal:  Nat Genet       Date:  2013-08-05       Impact factor: 38.330

View more
  26 in total

Review 1.  Regulation of large and small G proteins by ubiquitination.

Authors:  Henrik G Dohlman; Sharon L Campbell
Journal:  J Biol Chem       Date:  2019-10-23       Impact factor: 5.157

Review 2.  Defective protein degradation in genetic disorders.

Authors:  Pau Castel
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-02-11       Impact factor: 5.187

3.  Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.

Authors:  Sisi Chen; Rahul S Vedula; Antonio Cuevas-Navarro; Bin Lu; Simon J Hogg; Eric Wang; Salima Benbarche; Katherine Knorr; Won Jun Kim; Robert F Stanley; Hana Cho; Caroline Erickson; Michael Singer; Dan Cui; Steven Tittley; Benjamin H Durham; Tatiana S Pavletich; Elise Fiala; Michael F Walsh; Daichi Inoue; Sebastien Monette; Justin Taylor; Neal Rosen; Frank McCormick; R Coleman Lindsley; Pau Castel; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2022-10-05       Impact factor: 38.272

4.  Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways.

Authors:  Gabriele Bonetti; Stefano Paolacci; Michele Samaja; Paolo Enrico Maltese; Sandro Michelini; Serena Michelini; Silvia Michelini; Maurizio Ricci; Marina Cestari; Astrit Dautaj; Maria Chiara Medori; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

5.  Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia.

Authors:  Zelong Cui; Yue Fu; Zongcheng Yang; Zhenxing Gao; Huimin Feng; Minran Zhou; Lu Zhang; Chunyan Chen
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

Review 6.  LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.

Authors:  Kirsten M Farncombe; Emily Thain; Carolina Barnett-Tapia; Hamid Sadeghian; Raymond H Kim
Journal:  BMC Med Genomics       Date:  2022-07-15       Impact factor: 3.622

Review 7.  Post-translational modification of RAS proteins.

Authors:  Sharon L Campbell; Mark R Philips
Journal:  Curr Opin Struct Biol       Date:  2021-08-06       Impact factor: 6.809

Review 8.  Diagnostic Pathology of Tumors of Peripheral Nerve.

Authors:  Sarra M Belakhoua; Fausto J Rodriguez
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

Review 9.  Ubiquitin ligases in cancer: Functions and clinical potentials.

Authors:  Shanshan Duan; Michele Pagano
Journal:  Cell Chem Biol       Date:  2021-05-10       Impact factor: 9.039

10.  Generation of a Mouse Model to Study the Noonan Syndrome Gene Lztr1 in the Telencephalon.

Authors:  Mary Jo Talley; Diana Nardini; Nisha Shabbir; Lisa A Ehrman; Carlos E Prada; Ronald R Waclaw
Journal:  Front Cell Dev Biol       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.